chemotherapy induced neuropathy. Drug-induced polyneuropathy
Conditions
Interventions
Intervention 1: Intervention group: Patients in this group from the time of commencing chemotherapy (or simultaneously with premedication), during the time of receiving the chemotherapy and 15 minute
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Consent to use the cooling device and complete the consent form The use of one of the chemotherapy regimens with the occurrence of neuropathy including drugs from the taxanes Performance more than 70% Age less than 75 years
Exclusion criteria
Exclusion criteria: History of melanoma History of systemic lupus erythematosus Poor controlled diabetes Dissatisfaction with using the device History of cryoglobulinemia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of neuropathy. Timepoint: Measuring the severity of neuropathy at the beginning of the study (before the start of the intervention) and the 6th and 12th sessions of chemotherapy and 3 months after the end of the treatment. Method of measurement: European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) Chemotherapy-Induced Peripheral Neuropathy (CIPN) 20.;Quality of Life. Timepoint: Measuring the severity of neuropathy at the beginning of the study (before the start of the intervention) and 3 months after the end of the treatment. Method of measurement: World Health Organization Quality of Life Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Alireza Javadinia
Sabzevar University of Medical Sciences
Outcome results
None listed